1994～2002年广西甲型副伤寒和伤寒流行情况分析

目的 了解1994～2002年接种伤寒Vi疫苗后的7年间伤寒和副伤寒流行变化，评价Vi疫苗对控制伤寒流行的效果并分析甲型副伤寒的特征及影响其爆发流行的因素。方法对自治区疾病控制中心实验室记录、伤寒副伤寒爆发调查报告、监测系统资料、全区伤寒流行地区伤寒Vi疫苗供应情况进行统计分析。结果 经过血培养证实甲型副伤寒病例为1200例、伤寒为285例；甲型副伤寒与伤寒的流行病学、临床特征十分相似；饮用污染水是引起甲型副伤寒爆发的主要原因；从1999年起，甲型副伤寒杆菌开始超过伤寒菌为优势流行菌株。结论 在广泛使用伤寒Vi疫苗后，伤寒基本得到控制，但因为引起副伤寒发病的危险因素依然存在，甲型副伤寒已取代寒，成为广西农村地区的最重要的传染病之一。为控制甲型副伤寒的流行，在安全饮用水供应状况得到全面改善之前，应尽快研制出副伤寒疫苗。     

北京地区伤寒沙门菌Vi-Ⅱ噬菌体型及其药物敏感性监测

于１９７３～１９８９年收集北京地区伤寒沙门菌９６１株，做Ｖｉ－Ⅱ噬菌体分型及药物敏感性监测。结果分出３８个噬菌体型，主要噬菌体型为Ａ，Ｄ２，Ｅ１，Ｋ１，Ｄ５，Ｄ１，Ｏ，Ｄ４及Ｌ１型。药敏试验表明，１６８株北京地区菌与９６型Ｖｉ－Ⅱ标准菌相似，它们均对氯霉素高度敏感。     

Typhoid fever in the neapolitan area: A case-control study

Typhoid fever is endemic in the Neapolitan area, where its yearly incidence rate largely exceeds the corresponding national figure. During the period from January to June, 1990, a matched case-control study was carried out in order to identify risk factors of the disease in this area; 51 subjects (mean age 27.2 years) with typhoid fever were compared with 102 controls matched with respect to age, sex and educational level. Consumption of raw shellfish was reported by 76.5% of the cases, as opposed to 19.6% of the controls (P < 0.01). Subjects who had eaten this food item had a 13.3-fold risk (C.I. 95% = 5.5 - 32.8) of contracting typhoid fever. In contrast, no risk was found to be associated with consumption of cooked shellfish, raw vegetables, ice-cream, non-potable water, or unpasteurized milk.The risk factor identified in this study shows that hazardous dietary habits and inadequate sewage treatment facilities, combined with lack of sanitation in the harvesting and marketing of shellfish, play a major role in the endemicity of typhoid fever in the Neapolitan area.Corresponding author.     

圆形分布在流行病学中的应用——2845例伤寒发病时间分析

应用圆分布分析法对莱芜市22年间两次伤寒流行的发病时间进行了分析。第一次流行在1958年—1968年共发生2239例,按月发病时间计算的平均角度为287.4°(291天),发病高峰在10月18日。第二次流行在1975年—1985年共发生606例,平均角度为294.5°(299天),发病高峰在10月26日。对两个平均角进行显著性检验,F=9.4,P<0.01。即两次流行发病时间的平均角间有高度显著性差异。     

2011—2020年湖南省伤寒、副伤寒流行病学特征和菌株耐药分析

目的 分析2011—2020年湖南省伤寒、副伤寒流行特征和菌株耐药情况,为做好伤寒、副伤寒防控工作提供依据。方法 收集2011—2020年湖南省伤寒、副伤寒监测数据,采用描述性流行病学方法分析三间分布特征,对各市州分离上送的67株伤寒、副伤寒沙门菌采用梅里埃VITEK2 Compact 全自动细菌鉴定及药敏分析系统进行细菌鉴定和药敏分析。结果 10年间湖南省共报告伤寒、副伤寒病例9 888例,死亡0例,年均发病率1.47/10万。发病人群以农民、散居儿童、学生为主,5—9月为高发季节,主要集中在湘南和湘西地区。2011—2020年湖南省共报告4起伤寒、副伤寒暴发疫情,暴发场所均为学校,传播途径均为水型传播。67株伤寒、副伤寒菌对头孢他啶、氨曲南和厄他培南100%敏感;对哌拉西林/他唑巴坦、头孢吡肟和复方新诺明敏感率为98.5%;对氨苄西林/舒巴坦敏感率为97.0%;对头孢唑林、头孢替坦、阿米卡星、庆大霉素和妥布霉素敏感性较低（＜10%）。55.3%菌株对三类及以上抗生素耐药,发现1株同时对8种抗生素耐药。结论 湖南省伤寒、副伤寒发病呈持续低发状态,局部地区存在暴发。菌株多重耐药现象严重,应加强疫情及耐药监测。     

2018年烟台市同期五起伤寒病原学研究及溯源分析

目的分析烟台市5起伤寒病原学特征及分子流行病学关联。方法2018年自烟台市5例伤寒确诊病例样本和流行病调查样本分离获得6株伤寒沙门菌菌株,病例发病时间自2018年5月26日至7月24日,分别分布于烟台牟平区水道镇、烟台蓬莱区登州街道、烟台龙口东莱街道、烟台牟平区文化街道、烟台芝罘区福莱山街道。采用常规细菌分离方法和XbaⅠ/BlnⅠ双酶切脉冲场凝胶电泳(PFGE)技术对伤寒杆菌进行溯源分析,同时开展viaB毒力基因检测和27种临床常用抗生素敏感试验对伤寒杆菌进行病原学研究。结果6株伤寒杆菌经PFGE-XbaⅠ和PFGE-BlnⅠ电泳分为4个PFGE模式,其中3株菌同源性100%;1株多耐药菌(外籍患者),1株单耐药菌(外省滞留史患者),1株完全敏感菌,同一PFGE模式的3株菌药敏表型一致,除对氨基糖甙类和喹诺酮类部分抗生素中介外,对其他抗生素均敏感;除外籍患者标本分离株viaB基因阴性外,其他菌viaB基因均阳性。结论烟台寒杆菌对临床常用抗生素敏感性良好,仍需重视伤寒散发病例发生和伤寒输入感染。     

Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study

BackgroundZimbabwe suffers from regular outbreaks of typhoid fever (TF), worse since 2017. Most cases were in Harare and a vaccination campaign with Typhoid Conjugate Vaccine (TCV) was conducted in March 2019. The vaccine effectiveness (VE) was assessed against culture-confirmed S. Typhi in children six months to 15 years and in individuals six months to 45 years in Harare.MethodsA matched case-control study was conducted in three urban suburbs of Harare targeted by the TCV vaccination campaign. Suspected TF cases were enrolled prospectively in four health facilities and were matched to facility (1:1) and community (1:5) controls.FindingsOf 504 suspected cases from July 2019 to March 2020, 148 laboratory-confirmed TF cases and 153 controls confirmed-negative were identified. One hundred and five (47 aged six months to 15 years) cases were age, sex, and residence matched with 105 facility-based controls while 96 cases were matched 1:5 by age, sex, and immediate-neighbour with 229 community controls.The adjusted VE against confirmed TF was 75% (95%CI: 1–94, p = 0.049) compared to facility controls, and 84% (95%CI: 57–94, p < 0.001) compared to community controls in individuals six months to 15 years. The adjusted VE against confirmed TF was 46% (95%CI: 26–77, p = 0.153) compared to facility controls, and 67% (95%CI: 35–83, p = 0.002) compared to community controls six months to 45 years old.InterpretationThis study confirms that one vaccine dose of TCV is effective to control TF in children between six months and 15 years old in an African setting.     

Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles,mumps and rubella containing vaccine in 9–15 months old Nepalese infants

BackgroundTyphoid fever is a common disease in developing countries especially in the Indian subcontinent and Africa. The available typhoid conjugate vaccines (TCV) have been found to be highly immunogenic in infants and children less than 2 years of age. Many countries are planning to adopt TCV in their routine EPI programs around 9 months of age when measles containing vaccines are given. Therefore, Vi-DT TCV was tested in 9–15 months aged healthy infants in Nepal to demonstrate non-interference with a measles containing vaccine.MethodsThis was a randomized, open label, phase III study to assess the immune non-interference, safety, and reactogenicity of Vi-DT typhoid conjugate vaccine when given concomitantly with measles, mumps and rubella (MMR) vaccine. A total of 360 participants aged 9–15 months were enrolled and randomized equally into Vi-DT + MMR (180 participants) or MMR alone (180 participants) group and were evaluated for immunogenicity and safety 28 days post vaccination.ResultsUsing the immunogenicity set, difference between proportions (95% CI) of the Vi-DT + MMR group vs MMR alone group were ?2.73% (-8.85, 3.38), ?3.19% (-11.25, 4.88) and 2.91% (-3.36, 9.18) for sero-positivity rate of anti-measles, anti-mumps and anti- rubella, respectively. Only the lower bound of the range in difference of the proportions for sero-positivity rate of anti-mumps did not satisfy the non-inferiority criteria as it was above the ?10% limit, which may not be of clinical significance. These results were confirmed in the per protocol set. There were no safety concerns reported from the study and both Vi-DT + MMR and MMR alone groups were comparable in terms of solicited and unsolicited adverse events .ConclusionsResults indicated that there is non-interference of MMR vaccine with Vi-DT and Vi-DT conjugate vaccine could be considered as an addition to the EPI schedule among children at risk of contracting typhoid.     

舒他西林、氧氟沙星、氯霉素治疗伤寒128例疗效观察

目的：评价三种抗菌素治疗伤寒的安全性和有效性。方法：将１２８例伤寒患者随机分为三组,分别予舒他西林３ｇ静滴,１次／日;氧氟沙星２００ｍｇ静滴,１次／日;氯霉素１ｇ静滴,１次／日。结果：总有效率舒他西林组为９７８％,氧氟沙星组为９２９％,氯霉素组为８０％。组间比较,舒他西林组与氯霉素组间有显著差异性,Ｐ＜００１。余两组间差异无显著性。副作用发生率：舒他西林组为４３％,氧氟沙星组为１４３％,氯霉素组为７５％。结论：舒他西林治疗伤寒疗效最好而副作用最少,可做为治疗伤寒的首选药物。     

Two outbreaks of typhoid fever related to the war in Bosnia and Herzegovina

Two outbreaks of typhoid fever caused by Salmonella typhi of the same phagotype (A, biotype II) and antibiotic susceptibility are reported. Both occurred during the war in Bosnia and Herzegovina. The first outbreak appeared among the refugees from the town of Jajce. The second outbreak appeared among the inhabitants in the village of Vidosi near Livno. This report describes main clinical, epidemioloigcal and laboratory findings for 22 patients treated in Split University Hospital, Croatia, in the period November 1992–January 1993. Possible epidemiological connections between those two outbreaks are discussed.